The investment marks the largest single life science investment in North Carolina history. It tops the $1.8 billion investment announcement in 2016 from Novo Nordisk for one of its facilities in ...

Novo Nordisk is ramping up the manufacturing capacity of its obesity-related drugs as demand for Wegovy and Ozempic continues ...

announcing plans to build a $4.1 billion fill-and-finish facility for injectables in North Carolina, US. The new plant will be one of the largest manufacturing investments in Novo Nordisk’s ...

Novo Nordisk's semaglutide ... One of these, at Clayton in North Carolina, will focus on producing active pharmaceutical ingredients (APIs) for isemaglutide and other diabetes drugs, while ...

Novo Nordisk Pharmaceutical Industries, a leading global healthcare company, has donated STEM kits to the Boys and Girls Club ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...